- Home
- ADTN vs SANA Comparison
ADTN vs SANA Comparison
Compare ADTN & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADTN | SANA |
|---|---|---|
| Founded | 1985 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 962.3M | 793.1M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ADTN | SANA |
|---|---|---|
| Price | $8.04 | $3.69 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $15.50 | $7.80 |
| AVG Volume (30 Days) | ★ 2.5M | 2.4M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.83 | 17.24 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,083,807,000.00 | N/A |
| Revenue This Year | $11.09 | N/A |
| Revenue Next Year | $8.47 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.46 | N/A |
| 52 Week Low | $7.11 | $2.61 |
| 52 Week High | $19.98 | $6.55 |
Technical Indicators
Market Signals| Indicator | ADTN | SANA |
|---|---|---|
| Relative Strength Index (RSI) | 32.34 | 60.09 |
| Support Level | $7.11 | $3.62 |
| Resistance Level | $9.14 | $3.75 |
| Average True Range (ATR) | 0.55 | 0.20 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 26.63 | 79.17 |
Price Performance
Historical ComparisonAbout ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.